JAC-Antimicrobial Resistance: 2023, vol: 5, issue: 5
- 1)- Azza Mohammed Khalifa Al Mamari, Zaaima Al Jabri, Hiba Sami, Syed Gauhar A Rizvi, Moon Fai Chan, Turkiya Al Siyabi, Zakariya Al Muharrmi, Meher Rizvi. Evaluation of six commercial and in-house phenotypic tests for detection of AmpC β-lactamases: is routine detection possible? JAC-antimicrobial resistance. 2023, 5 (5): dlad101
Cited : 0Read More - 2)- Bridget Olson, Noam Ship, Michael L Butera, Kenneth Warm, Roger Oen, John Howard. infection in a skilled nursing facility (SNF): cost savings of an automated, standardized probiotic antimicrobial stewardship programme (ASP) policy. JAC-antimicrobial resistance. 2023, 5 (5): dlad102Cited : 1Read More
- 3)- Charlotte Brookfield, Emma Fadden, Louise Sweeney. Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) . JAC-antimicrobial resistance. 2023, 5 (5): dlad103Cited : 0Read More
- 4)- S Jahanbakhsh, J Howland, M O Ndayishimiye Uwineza, M T Thwaites, C M Pillar, A W Serio, D M Anastasiou, D A Hufnagel. Evaluation of omadacycline against intracellular in an infection model in human macrophages. JAC-antimicrobial resistance. 2023, 5 (5): dlad104Cited : 0Read More
- 5)- Shamim Nabidda, Rogers Ssennyonjo, Joseph Atwaru, Andrew Marvin Kanyike, Shiellah Baryayaka, Kennedy Pangholi, Jonans Tusiimire. Antimicrobial resistance and rational prescription practices: knowledge, perceptions and confidence of health profession interns in Uganda. JAC-antimicrobial resistance. 2023, 5 (5): dlad105Cited : 1Read More
- 6)- Kazuko Ikegaya, Kotaro Aoki, Kohji Komori, Yoshikazu Ishii, Kazuhiro Tateda. Analysis of the stepwise acquisition of and subsequent acquisition of either or in highly conserved IncN-pST5 plasmids. JAC-antimicrobial resistance. 2023, 5 (5): dlad106Cited : 1Read More
- 7)- Ryan K Shields, Ellen G Kline, Kevin M Squires, Daria Van Tyne, Yohei Doi. activity of cefiderocol against demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors. JAC-antimicrobial resistance. 2023, 5 (5): dlad107Cited : 2Read More
- 8)- Matúš Dohál, Věra Dvořáková, Miluše Šperková, Martina Pinková, Andrea Spitaleri, Erik Michael Rasmussen, Mária Škereňová, Michaela Krivošová, Eduard Gondáš, Igor Porvazník, Ivan Solovič, Daniela Maria Cirillo, Juraj Mokrý. Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGS. JAC-antimicrobial resistance. 2023, 5 (5): dlad108Cited : 0Read More
- 9)- Ahmed A Sadeq, Farah Ahmed Issa, Mina Bakhit, Maitha Abdul-Aziz Al-Tamimi, Zahir Osman Eltahir Babiker, Raghad S Ismail Alshabebi, Jehad Abdallah, Emmanuel Fru Nsutebo, Marleine B Moukarzel, Rawan Abukhater, Barbara R Conway, Stuart E Bond, Sidra Khan, Mamoon A Aldeyab. Exploring drivers and challenges influencing antibiotic prescribing in outpatient settings and possible mitigation strategies in the United Arab Emirates: a qualitative study. JAC-antimicrobial resistance. 2023, 5 (5): dlad109Cited : 0Read More
- 10)- Willi Quino, Gustavo Bellido, Diana Flores-León, Junior Caro-Castro, Orson Mestanza, Jorge Lucero, Ronnie G Gavilan. Trends in antimicrobial resistance of species in Peru, 2011-2020. JAC-antimicrobial resistance. 2023, 5 (5): dlad110Cited : 0Read More
- 11)- Juan-Carlos Jiménez-Castellanos, Elizabeth Pradel, Nina Compagne, Anais Vieira Da Cruz, Marion Flipo, Ruben C Hartkoorn. Characterization of pyridylpiperazine-based efflux pump inhibitors for . JAC-antimicrobial resistance. 2023, 5 (5): dlad112Cited : 2Read More
- 12)- Tara M Rogers, Ellen G Kline, Marissa P Griffith, Chelsea E Jones, Abigail M Rubio, Kevin M Squires, Ryan K Shields. Mutations in differentially impact synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing . JAC-antimicrobial resistance. 2023, 5 (5): dlad113Cited : 1Read More
